Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 561 Name quiflox
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Quiflox 80 mg V/DCP/12/0075 KRKA, d.d., Novo mesto, Slovēnija QJ01MA93 dogs

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Jan-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0075-01 80 mg 2 OPA/Al/PVH-Al blisteris, 6 tablete -
V/DCP/12/0075-02 80 mg 12 OPA/Al/PVH-Al blisteris, 6 tablete -
Quiflox 5 mg V/DCP/12/0073 KRKA, d.d., Novo mesto, Slovēnija QJ01MA93 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Jan-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0073-01 5 mg 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/12/0073-02 5 mg 10 OPA/Al/PVH-Al blisteris, 10 tablete -
Quiflox 20 mg V/DCP/12/0074 KRKA, d.d., Novo mesto, Slovēnija QJ01MA93 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 03-Jan-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0074-01 20 mg 1 OPA/Al/PVH-Al blisteris, 10 tablete -
V/DCP/12/0074-02 20 mg 10 OPA/Al/PVH-Al blisteris, 10 tablete -
Quiflox 100 mg/ml V/DCP/11/0016 KRKA, d.d., Novo mesto, Slovēnija QJ01MA93 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Marbofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 26-Jan-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0016-01 100 mg/ml 1 Stikla pudele, 50 ml -
V/DCP/11/0016-02 100 mg/ml 1 Stikla pudele, 100 ml -
V/DCP/11/0016-03 100 mg/ml 1 Stikla pudele, 250 ml -

4 records · Download

  • 1
© Food and veterinary service · 2026 Cookies policy